What is discitis osteomyelitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discitis Osteomyelitis: Definition, Diagnosis, and Management

Discitis osteomyelitis is an infection of the intervertebral disc and adjacent vertebral bodies, often resulting from hematogenous seeding from a distant focus, with potential extension to paravertebral and epidural soft tissues. 1

Epidemiology and Pathophysiology

  • Native vertebral osteomyelitis (NVO) occurs most commonly through hematogenous seeding of the adjacent disc space from a distant infectious focus, as the disc itself is avascular 1
  • The incidence is approximately 2.4 cases per 100,000 annually, increasing with age to over 6/100,000 in adults over 70 years 2
  • Approximately 80% of cases are hematogenous in origin, while 20% develop after spinal surgery 2
  • The infection typically begins with a septic embolus to the vertebral endplate, then spreads to the adjacent disc 1

Clinical Presentation

  • Recalcitrant back or neck pain unresponsive to conservative measures is the most common presenting symptom 1
  • Fever may or may not be present 1
  • Elevated inflammatory markers (ESR, CRP) are typically present 1
  • Neurologic symptoms may occur if there is extension to the epidural space 1
  • Diagnosis is often delayed by several months and initially misdiagnosed as a degenerative process 1

Risk Factors

  • Recent bloodstream infection, particularly Staphylococcus aureus 1
  • Infective endocarditis 1
  • Immunocompromised state 1
  • Advanced age 1
  • Intravenous drug use 1, 3
  • Diabetes, long-term steroid use, liver failure, and renal failure 1
  • Recent spinal procedures or surgery 3

Diagnostic Approach

Clinical Suspicion

  • Suspect discitis osteomyelitis in patients with:
    • New or worsening back/neck pain with fever 1
    • New or worsening back/neck pain with elevated ESR or CRP 1
    • New or worsening back/neck pain with recent bloodstream infection or endocarditis 1
    • Fever with new neurologic symptoms with or without back pain 1

Imaging

  • MRI is the imaging modality of choice (sensitivity 97%, specificity 93%, accuracy 94%) 1
    • Characteristic findings include inability to distinguish margins between disc space and adjacent vertebral marrow on T1-weighted images, with increased signal intensity on T2-weighted images 1
    • Gadolinium enhancement may be the first sign of acute inflammation 1
  • If MRI is contraindicated (implantable devices, claustrophobia):
    • Consider combination spine gallium/Tc99 bone scan, CT scan, or PET scan 1
  • Plain radiographs have limited sensitivity in early disease 1
  • CT is superior to radiographs for detecting early bone changes, with abnormalities visible in nearly half of patients within the first 2 weeks 1

Microbiologic Diagnosis

  • Blood cultures should be obtained in all patients 1
  • Image-guided aspiration biopsy is recommended in patients with suspected discitis osteomyelitis 1
  • If paravertebral fluid collections are present, CT-guided aspiration should be performed 3
  • The yield of CT-guided percutaneous sampling is 31-91% 3
  • Consider withholding antibiotics for 1-2 weeks before biopsy if clinically feasible 3
  • If initial biopsy is negative, consider repeat biopsy after 72 hours 3
  • In patients with S. aureus bloodstream infection within the preceding 3 months and compatible MRI findings, disc space aspiration may not be necessary 1

Microbiology

  • Discitis osteomyelitis is commonly monomicrobial 1
  • Staphylococcus aureus is the most frequent causative organism (40-60%) 1, 2
  • Tuberculosis accounts for approximately 20% of cases 2
  • Consider Brucella species in patients from endemic areas 1
  • Consider fungal pathogens in immunocompromised hosts 1

Treatment

Antimicrobial Therapy

  • Definitive therapy should be based on culture results and susceptibility testing 1
  • Antibiotic therapy for 4-8 weeks appears to provide the optimal balance of efficacy and treatment duration for most patients with discitis osteomyelitis 4
  • Empiric antibiotics should be withheld until microbiologic diagnosis is established, except in patients with:
    • Hemodynamic instability
    • Sepsis or septic shock
    • Progressive or severe neurologic symptoms 1

Surgical Intervention

  • Surgical intervention is indicated for:
    • Progressive neurologic deficits
    • Progressive deformity
    • Spinal instability with or without pain despite adequate antimicrobial therapy 1
  • Consider surgical debridement with or without stabilization for:
    • Persistent or recurrent bloodstream infection without alternative source
    • Worsening pain despite appropriate medical therapy 1
  • Surgery is generally not recommended when bony imaging findings worsen at 4-6 weeks if clinical symptoms, physical examination, and inflammatory markers are improving 1

Monitoring Response to Treatment

  • Monitor systemic inflammatory markers (ESR and/or CRP) after approximately 4 weeks of antimicrobial therapy 1
  • ESR values >50 mm/hour and CRP values >2.75 mg/dL after 4 weeks of treatment may indicate higher risk of treatment failure 1
  • Routine follow-up MRI is not recommended in patients with favorable clinical and laboratory response 1
  • Consider follow-up MRI to assess evolutionary changes in epidural and paraspinal soft tissues in patients with poor clinical response 1
  • Improvement in paravertebral and epidural soft tissue on follow-up MRI correlates best with clinical improvement 1

Differential Diagnosis

  • Non-infectious processes can mimic infectious discitis/osteomyelitis:
    • Pseudarthrosis in ankylosing spondylitis
    • Amyloidosis
    • Destructive spondyloarthropathy of hemodialysis
    • Modic changes type 1
    • Neuropathic arthropathy
    • Calcium pyrophosphate dehydrate spondyloarthropathy
    • Gout 5

Prognosis

  • Mortality rates have improved from approximately 25% in the pre-antibiotic era to 0-11% in contemporary cohorts 1
  • Factors associated with worse outcomes may include:
    • Multidisc disease
    • Concomitant epidural abscess
    • Lack of surgical therapy when indicated
    • Infection with S. aureus
    • Advanced age
    • Significant comorbidities 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.